Gilvetmab Antibody is a research-grade biosimilar monoclonal antibody targeting CD279. It is a caninized IgG2-kappa antibody. Reactivity: Canine. Supplied as a liquid in 0.01M PBS pH 7.4. Applications: ELISA, flow cytometry, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% purity as determined by SDS-PAGE. For research use only.
Gilvetmab is a potent caninized anti-PD-1 monoclonal antibody. gilvetmab blocks the interaction between PD-1 and its ligand PDL-1. • Diagnostic value of soluble programmed cell death protein-1 in type-1 autoimmune hepatitis in Egyptian children., PMID:31762332
Product Name:
Gilvetmab Antibody
SKU:
GXBS01350
Size:
100 µg, 1 mg
Antibody Type:
Monoclonal Antibody
Target:
CD279
Isotype:
IgG2-kappa
Host Species:
Canine
Reactivity:
Canine
Applications:
ELISA, FCM, Functional assay, Research in vivo
Synonyms:
AH-PD1, 1808081-43-7
Recommended Dilutions:
ELISA: 1:2000-1:20000
Purity:
>95% as determined by SDS-PAGE.
Endotoxin Level:
< 10 EU/mg
Formulation:
0.01M PBS pH 7.4.
State of Matter:
Liquid
Regulatory Status:
For research use only. Not suitable for clinical or therapeutic use.
Product Preparation:
Protein A/G purified from cell culture supernatant.
Storage and Handling:
Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
